SPIA
RDY icon

Steward Partners Investment Advisory’s Dr. Reddy's Laboratories RDY Stock Holding History

Steward Partners Investment Advisory’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,790
Closed -$25K – 4440
2025
Q3 		$25K Buy
+1,790
New +$25.8K ﹤0.01% 2982

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Steward Partners Investment Advisory's RDY Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 1,790 shares — an estimated $25K sold.

Steward Partners Investment Advisory first reported a position in RDY in Q3 2025 and held it in 1 quarter. The position peaked at $25K in Q3 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,790 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $25K.
  • Steward Partners Investment Advisory first reported a position in Dr. Reddy's Laboratories in Q3 2025 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Dr. Reddy's Laboratories position peaked at $25K in Q3 2025.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.